
Consultant Review & Consent
Your Trust confirms the MDT decision, prescription and patient consent, identifies the patient as suitable for homecare and refers them to HealthNet.
Patient Support Team: 0800 083 3060 - Mon-Fri: 8am - 6pm, Sat: 8am - 5pm

HealthNet SACT Services
Systemic Anti-cancer Therapy (SACT), Delivered Safely at Home
HealthNet's SACT homecare service allows eligible patients to receive their treatment at home, delivered by specialist nurses under full consultant oversight. The Trust keeps clinical ownership throughout the pathway. We deliver the nursing, assessment and administration in the community.
Click here to speak to a member of the team about SACT services.
Moving suitable patients out of the hospital and into their own home helps the Trust and your patients. Four benefits:
Financial value - Potential savings for your Trust by avoiding chemotherapy chair occupancy, consumables and administrative activity for each patient moved to homecare. It can also reduce Trust-funded patient transport and parking costs.
Capacity - Every home administration releases a chemotherapy chair slot for patients who need hospital-based treatment, such as higher-acuity treatments. Capacity is created, supporting the 62-day and other cancer waiting-time standards.
Patient experience and choice - No travel, parking or waiting-room time, and treatment in familiar surroundings. It is particularly valuable for rural or coastal patients, and for those with mobility, frailty or caring constraints. Patients can opt back into hospital-based treatment at any point.
Workforce and sustainability - Less demand on chemotherapy nurses, outpatient nurses and pharmacy teams, freeing specialist capacity for higher-acuity patients. Fewer hospital journeys also support NHS sustainability objectives.


Consultant Review & Consent
Your Trust confirms the MDT decision, prescription and patient consent, identifies the patient as suitable for homecare and refers them to HealthNet.

Home Visit Scheduled
HealthNet consents the patient for homecare and agrees a visit time window with them.

Pre-treatment Assessment & Bloods
A HealthNet SACT nurse carries out the pre-treatment assessment and takes a blood sample. Your pathology lab analyses it and your clinical team reviews the results.

Treatment Administered at Home
The SACT nurse reconfirms the patient is fit for treatment, consents them and administers it. The visit record goes to the patient's consultant, and HealthNet schedules the next treatment.

Monitoring
Ongoing clinical monitoring stays with your Trust.
Note: Your Trust remains responsible for: Prescribing and MDT decision-making, Eligibility and consultant approval, Results review, and ongoing clinical monitoring. HealthNet is responsible for: Pre-treatment assessments, Blood sampling, Administration at home, and immediate post-dose care in the community.
Once your team deems a patient suitable and they consent, the pathway runs in four stages, repeating for each treatment. Eligibility criteria are agreed with your Trust and consultants.
The referring hospital team
Identifies the patient as suitable, deems them suitable for SACT homecare, obtains consent for home treatment, and sends the referral and documentation, including the prescription to HealthNet.
HealthNet
Registers the patient and checks the documentation is complete. Pharmacy screens the prescription. The team welcomes the patient, confirms consent and arranges the pre-assessment and blood visit.
HealthNet
SACT nurse visits the patient's home for the pre-assessment and takes bloods to your pathology laboratory. The homecare pharmacist and treating SACT nurse check results. The prescription is released for dispensing and delivered by cold chain, or by the nurse.
The referring hospital team
Checks the blood results.
HealthNet
The SACT nurse carries out the pre-treatment assessment,and administers the treament as per protocol. They complete the Clinical Evaluation Form (CEF), observe the patient after treatment to ensure they are well and safe, dispose of hazardous waste safely and leave the home.
The referring hospital team
Retains clinical oversight.
HealthNet
Stores the visit record in the patient's notes on HealthNet's CRM system. The Trust is invoiced for the treatment and service per the SLA. The process then repeats between appointments, patients can contact their Cancer CNS and the 24-hour, 7-day helpline through the NHS Trust.
The referring hospital team
Receives the CEF.

The service operates within your existing NHS governance frameworks, with the Trust retaining clinical ownership throughout. Only clinically appropriate, consenting patients are eligible for home administration, following consultant approval.
Consultant-led prescribing and patient eligibility criteria
Clinical protocols, adverse event management and escalation pathways
Electronic documentation, with each visit record sent to the patient's consultant
Medicines optimisation, audit and quality assurance
A review of clinical results by your team before every treatment, and a nurse check of how the patient is feeling before administration
What it could mean for your Trust
Aligned with national policy. The service supports the direction set out in the National Cancer Plan for England (2026), which supports community and home-based cancer treatment where it is safe and cost-effective, and the NHS 10 Year Health Plan (2025), which sets the shift from hospital to community and greater patient control over where care is delivered.

Speak to your HealthNet Business Development Manager about how the service could work for your Trust, including a view of the benefits for your own patient population.
We provide clinical homecare services for patients across the UK: delivering medicines safely and on time, offering nurse support and administration for treatments that need specialist care, and giving access to tailored patient support. Our goal is to support the NHS in making treatment easier, safer and more comfortable for patients.
Quick Links





